Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Br J Nutr ; 127(9): 1404-1414, 2022 05 14.
Artigo em Inglês | MEDLINE | ID: mdl-34176526

RESUMO

Se reduces cellular inflammation and lipid peroxides; therefore, its association with CVD and the metabolic syndrome (MetS) has been studied. We aimed to investigate the association between Se intake and the MetS and its parameters (high waist circumference, hyperglycaemia, high blood pressure, high TAG and low HDL-cholesterol) in Brazilian adolescents between 12 and 17 years old. This research is part of the Study of Cardiovascular Risks in Adolescents (ERICA), a Brazilian nationwide school-based study with regional and national relevance. We assessed: (1) socio-demographic data (sex, age, type of school and maternal education) using a self-administered questionnaire; (2) dietary intake using a 24-h recall applied for the whole sample and a second one applied to a subsample to allow within-person variability adjustment; (3) anthropometric data (weight, height, waist circumference) and blood pressure using standardised procedures; and (4) biochemical analyses (fasting glucose, TAG and HDL-cholesterol). Logistic regression was applied, basing the analysis on a theoretical model. Median Se intake was 98·3 µg/d. Hypertension and hyperglycaemia were more prevalent among boys, while a high waist circumference was more frequent in girls, and low HDL-cholesterol levels were higher among private school students. The prevalence of the MetS was 2·6 %. No association between the MetS and its parameters and Se intake was found. This lack of association could be due to an adequate Se intake in the studied population.


Assuntos
Doenças Cardiovasculares , Hiperglicemia , Hipertensão , Síndrome Metabólica , Selênio , Masculino , Feminino , Humanos , Adolescente , Criança , Síndrome Metabólica/epidemiologia , Fatores de Risco , Doenças Cardiovasculares/epidemiologia , Brasil/epidemiologia , Glicemia/análise , Fatores de Risco de Doenças Cardíacas , Circunferência da Cintura , Colesterol , Índice de Massa Corporal , Triglicerídeos
2.
In. Magnoni, Daniel; Stefanuto, Aline; Kovacs, Cristiane. Nutrição ambulatorial em Cardiologia. São Paulo, Sarvier, 2007. p.69-80.
Monografia em Português | LILACS, Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-1074433
3.
Nutrition ; 20(2): 200-4, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14962687

RESUMO

OBJECTIVE: This study assessed whether the consumption of soy milk could add significantly to the lipid profile and lipid peroxidation in comparison with non-fat milk. METHODS: A double-blind, randomized, crossover study was conducted on 60 outpatients with primary hypercholesterolemia following a lipid-lowering diet for at least 6 wk. Lipid profile was obtained at baseline and at 6 and 12 wk, with the patients randomly assigned to receive initially 1 L/d of soy milk or non-fat cow milk for 6 wk. Lipid peroxidation was estimated by plasma thiobarbituric reactive substances. Apolipoprotein E genotypes were examined by polymerase chain reaction restriction fragment length polymorphism. RESULTS: The soy milk diet was associated with low-density lipoprotein cholesterol reduction (baseline = 157 +/- 5 mg/dL; soy milk = 148 +/- 4 mg/dL; non-fat cow milk = 158 +/- 4 mg/dL; P < 0.05, soy milk versus other treatments) and with high-density lipoprotein cholesterol increase (baseline = 58 +/- 2 mg/dL; soy milk = 62 +/- 2 mg/dL; non-fat cow milk = 57 +/- 2 mg/dL; P < 0.05, soy milk versus other treatments). In addition, plasma thiobarbituric reactive substances were reduced by the soy milk diet (baseline = 1.82 +/- 0.12 nM/L; soy milk = 1.49 +/- 0.09 nM/L; non-fat cow milk = 1.91 +/- 0.11 nM/mL; P < 0.05, soy milk versus non-fat cow milk). Changes in lipid profile were not influenced by APOE genotypes. CONCLUSIONS: These results indicate that soy milk as part of a lipid-lowering diet has beneficial effects in improving lipid profile and reducing lipid peroxidation.


Assuntos
Hipercolesterolemia/sangue , Hipercolesterolemia/dietoterapia , Peroxidação de Lipídeos/efeitos dos fármacos , Lipídeos/sangue , Leite , Leite de Soja , Adulto , Idoso , Animais , Apolipoproteínas E/sangue , Apolipoproteínas E/genética , HDL-Colesterol/sangue , LDL-Colesterol/sangue , Estudos Cross-Over , Método Duplo-Cego , Feminino , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo de Fragmento de Restrição , Leite de Soja/administração & dosagem , Substâncias Reativas com Ácido Tiobarbitúrico/análise
4.
Pediatr. mod ; 35(1/2): 929-30, 932, 934, passim, jan.-fev. 1999. tab
Artigo em Português | LILACS | ID: lil-263061

RESUMO

Os autores realizam uma revisäo sobre a conduta diagnóstica e terapêutica nas hiperlipidemias na faixa etária pediátrica. Inicialmente apresentam as vias de produçäo das lipoproteínas, classificando as dislipidemias e mencionando as indicaçöes para a mensuraçäo dos níveis lipídicos em crianças: além da interpretaçäo dos testes laboratoriais, é apresentado um esquema terapêutico baseado na orientaçäo nutricional, estímulo à atividade física, modificaçäo do estilo de vida e utilizaçäo da terapêutica medicamentosa


Assuntos
Humanos , Criança , Adolescente , Hipercolesterolemia/diagnóstico , Hipercolesterolemia/dietoterapia , Hipercolesterolemia/tratamento farmacológico , Hiperlipoproteinemias/diagnóstico , Hiperlipoproteinemias/dietoterapia , Hiperlipoproteinemias/tratamento farmacológico , LDL-Colesterol/efeitos adversos , Anticolesterolemiantes/administração & dosagem , Anticolesterolemiantes/uso terapêutico , Lipoproteínas/sangue , Aterosclerose/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...